JANUX THERAPEUTICS INC Share Price Today: Live Updates & Key Insights
JANUX THERAPEUTICS INC share price today is $14.13, up -0.71%. The stock opened at $14.115 against the previous close of $14.16, with an intraday high of $14.25 and low of $13.795.
JANUX THERAPEUTICS INC Share Price Chart
JANUX THERAPEUTICS INC
JANUX THERAPEUTICS INC Share Price Performance
JANUX THERAPEUTICS INC Institutional Holdings
JANUX THERAPEUTICS INC Market Status
JANUX THERAPEUTICS INC Fundamentals
Market Cap 855.29 M
PB Ratio 0.8936
PE Ratio 0.0
Enterprise Value -89.44 M
Total Assets 1001.57 M
Volume 5037262
JANUX THERAPEUTICS INC Company Financials
About JANUX THERAPEUTICS INC & investment objective
Company Information Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr), Tumor Activated Immunomodulator (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms technology to treat patients with cancer. The company's clinical candidates include JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor that is in Phase 1 clinical trial for the treatment of various solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, renal cell carcinoma, small cell lung cancer, pancreatic ductal adenocarcinoma, and triple-negative breast cancer. It also develops JANX011, a CD19-targeted adaptive immune response modulator that is in phase 1 clinical study developed for autoimmune diseases. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates; and Bristol Myers Squibb to develop and commercialize an undisclosed, novel tumor-activated therapeutic targeting a validated solid tumor antigen expressed across several human cancer types. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
Organisation Biotechnology
Employees 109
Industry Biotechnology
CEO Dr. David Alan Campbell Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
JANUX THERAPEUTICS INC FAQs
What is the share price of JANUX THERAPEUTICS INC today?
The current share price of JANUX THERAPEUTICS INC is $14.13.
Can I buy JANUX THERAPEUTICS INC shares in India?
Yes, Indian investors can buy JANUX THERAPEUTICS INC shares by opening an international trading and demat account with Motilal Oswal.
How to buy JANUX THERAPEUTICS INC shares in India?
You can easily invest in JANUX THERAPEUTICS INC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy JANUX THERAPEUTICS INC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of JANUX THERAPEUTICS INC.
Can I buy fractional shares of JANUX THERAPEUTICS INC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of JANUX THERAPEUTICS INC?
JANUX THERAPEUTICS INC has a market cap of $855.29 M.
In which sector does JANUX THERAPEUTICS INC belong?
JANUX THERAPEUTICS INC operates in the Biotechnology sector.
What documents are required to invest in JANUX THERAPEUTICS INC stocks?
To invest, you typically need:
What is the PE and PB ratio of JANUX THERAPEUTICS INC?
The PE ratio of JANUX THERAPEUTICS INC is N/A and the PB ratio is 0.89.